ATE82848T1 - Stabilisierte 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende, parenteral anzuwendende loesung und verfahren zu deren herstellung. - Google Patents

Stabilisierte 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende, parenteral anzuwendende loesung und verfahren zu deren herstellung.

Info

Publication number
ATE82848T1
ATE82848T1 AT89118956T AT89118956T ATE82848T1 AT E82848 T1 ATE82848 T1 AT E82848T1 AT 89118956 T AT89118956 T AT 89118956T AT 89118956 T AT89118956 T AT 89118956T AT E82848 T1 ATE82848 T1 AT E82848T1
Authority
AT
Austria
Prior art keywords
phenyl
benzisoselenazole
stabilized
production
parenteral solution
Prior art date
Application number
AT89118956T
Other languages
English (en)
Inventor
Joerg Hager
Andrea Michaela Huether
Joachim Roeding
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of ATE82848T1 publication Critical patent/ATE82848T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
AT89118956T 1988-10-29 1989-10-12 Stabilisierte 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende, parenteral anzuwendende loesung und verfahren zu deren herstellung. ATE82848T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3836892A DE3836892A1 (de) 1988-10-29 1988-10-29 Parenteral applizierbare, stabile arzneimittelloesungen
EP89118956A EP0366990B1 (de) 1988-10-29 1989-10-12 Stabilisierte 2-Phenyl-1,2-benzisoselenazol-3(2H)-on enthaltende, parenteral anzuwendende Lösung und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE82848T1 true ATE82848T1 (de) 1992-12-15

Family

ID=6366157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89118956T ATE82848T1 (de) 1988-10-29 1989-10-12 Stabilisierte 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende, parenteral anzuwendende loesung und verfahren zu deren herstellung.

Country Status (12)

Country Link
EP (1) EP0366990B1 (de)
JP (1) JPH0832629B2 (de)
AT (1) ATE82848T1 (de)
CA (1) CA2001325C (de)
DE (2) DE3836892A1 (de)
DK (1) DK173610B1 (de)
ES (1) ES2052859T3 (de)
FI (1) FI94835C (de)
GR (1) GR3006865T3 (de)
IE (1) IE63152B1 (de)
NO (1) NO179196C (de)
PT (1) PT92142B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201527A1 (de) * 1992-01-21 1993-07-22 Knoll Ag Lecithinhaltige loesungen mit levemopamil
US5720973A (en) * 1993-02-18 1998-02-24 Knoll Aktiengesellschaft Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US7671211B1 (en) 1999-03-31 2010-03-02 Arne Holmgren Substrates for thioredoxin reductase
WO2002053154A1 (en) * 2000-12-28 2002-07-11 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical emulsion preparation
JP5846711B2 (ja) * 2005-06-09 2016-01-20 メダ アーベー 炎症性疾患の治療のための方法及び組成物
BRPI0615032A2 (pt) * 2005-09-01 2011-04-26 Biolipox Ab composição farmacêutica, processo para a preparação da mesma, e, uso de uma composição
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
EP0165534B1 (de) * 1984-06-22 1989-03-15 A. Nattermann & Cie. GmbH S-(Carbamoyl-phenylselenyl)-Derivate des Glutathions und von Aminomercaptocarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
CA2001325A1 (en) 1990-04-29
EP0366990A3 (en) 1990-12-19
GR3006865T3 (de) 1993-06-30
PT92142A (pt) 1990-04-30
DK173610B1 (da) 2001-04-30
NO179196C (no) 1996-08-28
NO894281L (no) 1990-04-30
DK537889A (da) 1990-04-30
CA2001325C (en) 1999-12-21
IE893492L (en) 1990-04-29
JPH02250876A (ja) 1990-10-08
ES2052859T3 (es) 1994-07-16
EP0366990A2 (de) 1990-05-09
NO179196B (no) 1996-05-20
NO894281D0 (no) 1989-10-26
FI895112A0 (fi) 1989-10-27
DK537889D0 (da) 1989-10-27
DE68903736T2 (de) 1993-04-08
EP0366990B1 (de) 1992-12-02
JPH0832629B2 (ja) 1996-03-29
IE63152B1 (en) 1995-03-22
FI94835B (fi) 1995-07-31
DE3836892A1 (de) 1990-05-03
FI94835C (fi) 1995-11-10
DE68903736D1 (de) 1993-01-14
PT92142B (pt) 1995-06-30

Similar Documents

Publication Publication Date Title
YU83786A (en) Process for obtaining hypoglicemic thiazolidindione
HUT44493A (en) Process for production of new derivatives of cycloalcane (1,2-b) indol-sulphinamid and medical preparatives containing these compounds
PT81839B (pt) Processo de preparacao de formulacoes com propulsores de aerosol a base de clorofluorocarbono contendo medicamento
HUP9802323A2 (hu) Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
ATE46164T1 (de) 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK319481A (da) Fremgangsmaade til fremstilling af forbindelse indeholdende 2-phenyl-1,2-benzioselenazol-3(2h)-on
ES2065906T3 (es) Produccion de proteinas en formas activas.
LTIP903A (en) Preparation process of solid pharmaceutical forms and such forms
DE68903736D1 (de) Stabilisierte 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende, parenteral anzuwendende loesung und verfahren zu deren herstellung.
EP0229016A3 (en) Interleukin-2 compositions
FR2614618B1 (fr) Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
HUT43831A (en) Process for production of derivatives of 1,2,3,4-tetrahydro-6-substituated-4-aryl or heterocyclic 3-substituated-2-tioxoor oxo-5-piramidine-carbonic acid and esther
FR2535721B1 (de)
HU9303227D0 (en) D-3 vitamine analogues and process for producing them
DE69117180D1 (de) Elektrochemische herstellung von sauren chloratloesungen
ATE36853T1 (de) Beta-carbolin-3-carbonsaeurederivate und methode zu ihrer herstellung.
DE68927649D1 (de) Verfahren zur Herstellung von 3',4'-Anhydrovinblastin
CS93189A2 (en) Method of substituted 5-halogenthienoisothiazole-3 (2h)-on-1,1-dioxides production
KR900009591A (ko) 피리딘-3-퍼옥시카르복실산 모노퍼술페이트
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
DE3678487D1 (de) Verfahren zur herstellung von 6-amino-3-hydrazino-pyridazinderivaten.
DE3774367D1 (de) Oxolabdane, verfahren zu deren herstellung und deren verwendung als arzneimittel.
ATE56871T1 (de) Lorazepam-haltiges schlafmittel.
FR2438656A1 (de)
ATE28621T1 (de) Verfahren zur herstellung von pharmakologisch aktiven verbindungen die eine sulfoxidgruppe enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time